Clinical Implications of Diet Inflammatory Index in Celiac Patients

Arzu Gülseren1, Aslıhan Besparmak2, Neşe Kaya2

  • 1Department of Pediatric Gastroenterology and Hepatology, Kayseri City Education and Research Hospital, Kayseri, Turkey.

Clinical Pediatrics
|February 19, 2026
PubMed

Insights

The dietary inflammation index (DII) in children with celiac disease (CD) correlates with disease markers and poorer anthropometric measurements, indicating inflammation impacts nutrition in these patients.

Area of Science:

  • Pediatric Nutrition
  • Gastroenterology
  • Immunology

Background:

  • Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion.
  • Nutritional status and inflammation are critical in managing pediatric CD.
  • The dietary inflammatory index (DII) quantifies the inflammatory potential of diets.

Purpose of the Study:

  • To investigate the dietary inflammation index (DII) in children with celiac disease (CD).
  • To assess the relationship between DII and clinical markers in pediatric CD.
  • To evaluate the effect of dietary inflammation on anthropometric measurements in children with CD.

Main Methods:

  • Cross-sectional study involving 47 pediatric patients (ages 5-18) diagnosed with CD.
  • Calculation of children-DII (c-DII) and energy consumption-DII (e-c-DII) scores.
  • Analysis of correlations between DII scores, serological markers (tTG-IgA, EMA), and anthropometric measurements.

Main Results:

  • Mean c-DII was 2.0 ± 1.0 and e-c-DII was 2.7 ± 0.8.
  • Significant correlations were found between c-DII/e-c-DII and tTG-IgA/EMA antibody levels.
  • Higher mean c-DII was observed in patients with low waist circumference, mid-upper arm circumference, and skinfold thickness (<10th percentile), with statistical significance.

Conclusions:

  • Dietary inflammation, as measured by c-DII, is significantly associated with serological markers of celiac disease activity.
  • Children with CD exhibiting higher dietary inflammatory scores tend to have poorer anthropometric measurements.
  • These findings highlight the substantial correlation between dietary inflammatory potential and nutritional status in pediatric celiac disease.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
940
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.2K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
823
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
817